Cargando…
Adult Langerhans Cell Histiocytosis and the Skeleton
Langerhans cell histiocytosis (LCH) is a rare inflammatory neoplasia in which somatic mutations in components of the MAPK/ERK pathway have been identified. Osseous involvement is evident in approximately 80% of all patients and may present as a single osteolytic lesion, as a multi-ostotic single sys...
Autores principales: | Georgakopoulou, Danae, Anastasilakis, Athanasios D., Makras, Polyzois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875624/ https://www.ncbi.nlm.nih.gov/pubmed/35207181 http://dx.doi.org/10.3390/jcm11040909 |
Ejemplares similares
-
Bone metabolism in Langerhans cell histiocytosis
por: Anastasilakis, Athanasios D, et al.
Publicado: (2018) -
Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series
por: Chellapandian, Deepak, et al.
Publicado: (2016) -
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
por: Anastasilakis, Athanasios D, et al.
Publicado: (2012) -
Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net
por: Girschikofsky, Michael, et al.
Publicado: (2013) -
Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation
por: Anastasilakis, Athanasios D., et al.
Publicado: (2020)